ABSTRACT
In medicine, external second opinions are frequently sought to inform decisions around a patient's proposed course of treatment. However, they are also sought in more challenging circumstances such as when disagreement arises between the healthcare team and the family, or during complex end-of-life discussions in critically ill children. When done well, external second opinions can help build trust and reduce conflict. However, when done poorly they may antagonise relationships and thwart attempts to bring about consensus. While principles of good medical practice should always be followed, the actual second opinion process itself remains essentially unregulated in all its forms. In this review, we set out what a standardised and transparent second opinion process should look like and recommend key recommendations for healthcare Trusts, Commissioners and professional bodies to support good practice.
Subject(s)
Dissent and Disputes , Referral and Consultation , Child , Humans , ConsensusABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is rarely fatal in children and young people (CYP, <18 years old), but quantifying the risk of death is challenging because CYP are often infected with SARS-CoV-2 exhibiting no or minimal symptoms. To distinguish between CYP who died as a result of SARS-CoV-2 infection and those who died of another cause but were coincidentally infected with the virus, we undertook a clinical review of all CYP deaths with a positive SARS-CoV-2 test from March 2020 to February 2021. The predominant SARS-CoV-2 variants were wild-type and Alpha. Here we show that, of 12,023,568 CYP living in England, 3,105 died, including 61 who were positive for SARS-CoV-2. Of these deaths, 25 were due to SARS-CoV-2 infection (mortality rate, two per million), including 22 due to coronavirus disease 2019-the clinical disease associated with SARS-CoV-2 infection-and 3 were due to pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2. In total, 99.995% of CYP with a positive SARS-CoV-2 test survived. CYP older than 10 years, Asian and Black ethnic backgrounds and comorbidities were over-represented in SARS-CoV-2-related deaths compared with other CYP deaths. These results are important for guiding decisions on shielding and vaccinating children. New variants might have different mortality risks and should be evaluated in a similar way.
Subject(s)
COVID-19/complications , COVID-19/mortality , Ethnicity/statistics & numerical data , Systemic Inflammatory Response Syndrome/mortality , Adolescent , Age Distribution , Asian People/statistics & numerical data , Black People/statistics & numerical data , COVID-19/epidemiology , COVID-19/ethnology , Cause of Death , Child , Child, Preschool , England/epidemiology , Female , Humans , Infant , Infant, Newborn , Male , SARS-CoV-2 , Systemic Inflammatory Response Syndrome/epidemiology , Systemic Inflammatory Response Syndrome/ethnology , White People/statistics & numerical dataSubject(s)
Ethics, Medical , Medical Tourism/ethics , Parents/psychology , Child , Humans , PediatricsSubject(s)
Child Health Services/standards , Consensus , Dissent and Disputes , Professional-Family Relations , Attitude of Health Personnel , Child , Health Personnel/psychology , Humans , Negotiating/methods , Palliative Care/psychology , Palliative Care/standards , Pediatricians/psychology , Terminal Care/psychology , Terminal Care/standards , United KingdomABSTRACT
A 16-year-old male patient with known hereditary spherocytosis presented with a 4-day history of chest pain and lethargy. On admission, he had a low-grade fever and was grossly anaemic; examination revealed splenomegaly. An ultrasound scan confirmed splenomegaly with areas of splenic infarction. Subsequent tests suggested possible Epstein-Barr virus infection. The patient recovered well and had a functional spleen on discharge. This case report presents an unusual complication of isolated hereditary spherocytosis.